Pfizer is forging ahead with plans to introduce a direct-to-consumer platform for online sales of some of its medications, including Paxlovid and a migraine nasal spray.
The Defender reports that this initiative marks the latest maneuver by major pharmaceutical companies to circumvent conventional routes of distribution through primary care physicians and brick-and-mortar pharmacies.
Pfizer is set to roll out its platform before the year’s end.
Its website will enable patients in the U.S. to consult independent telehealth professionals for prescriptions, with an online pharmacy partner handling the fulfillment and shipping of orders, per the Financial Times.
Hellbound and Down 